Subscribe
Home
Issues
2022
June 2022 - Vol 15 No 3
April 2022 - Vol 15 No 2
February 2022 - Vol 15 No 1
2021
December 2021 - Vol 14 No 6
October 2021 - Vol 14 No 5
August 2021 - Vol 14 No 4
June 2021 - Vol 14 No 3
April 2021 - Vol 14 No 2
February 2021 - Vol 14 No 1
2020
December 2020, Vol 13, No 6
October 2020, Vol 13, No 5
August 2020, Vol 13, No 4
June 2020, Vol 13, No 3
April 2020 - Vol 13, No 2
Issue Archive
Special Issues
Supplements
ASK THE EXPERT:
First-Line Treatment of Metastatic Non-Small-Cell Lung Cancer: Checkmate 9LA
First-Line Treatment of Metastatic Non-Small-Cell Lung Cancer: Checkmate 227
Guide to New FDA Approvals
2021 Year in Review
Multiple Myeloma
Advances in Dual Immunotherapy Cancer Treatments
Ovarian Cancer
HER2-Negative Breast Cancer
Triple-Negative Breast Cancer
Renal-Cell Carcinoma
Biosimilars
Gastrointestinal Cancer
Non–Small-Cell Lung Cancer
Categories
Conference Correspondent
ASCO 2021 - Breast Cancer
ASCO 2020 - Lung Cancer
ASH 2019 Wrap-Up
ASH 2019 MM
Web Exclusives
All Web Exclusives
Breast Cancer Monthly Minutes
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes
Interview with the Innovators
Drug Updates
FDA Approvals, News & Updates
In the News
Online First
Press Releases
Media Library
Videos
Audiocasts
Ask the Experts
Master Class Series
Quick Quiz
CE
Web Exclusives
Examining the Nutritional Status and Treatment Protocols of Patients with NSCLC
Lung Cancer
Web Exclusives
Researchers identified an association between nutritional status, treatment protocols, and survival in patients with advanced non–small-cell lung cancer.
Read More ›
PD-1/PD-L1 Monoclonal Antibody Use Is Effective in Young and Elderly Patients with NSCLC
Lung Cancer
Web Exclusives
Recently released study findings on PD-1/PD-L1 immunotherapy in young and elderly patients with metastatic NSCLC found the treatment is safe and effective in both patient cohorts.
Read More ›
Next-Generation Sequencing in Lung Cancer Found to Be Accurate and Cost-Effective
Lung Cancer
Web Exclusives
Next-generation sequencing for targetable mutations in lung cancer is as accurate as single-gene testing with minimal increase in testing cost.
Read More ›
Immune Checkpoint Inhibitors May Have Limited Efficacy in Patients with NSCLC with Poor Performance Status
Lung Cancer
Web Exclusives
A recent review article examined the limited benefit associated with immune checkpoint inhibitor use in patients with non–small-cell lung cancer with poor performance status.
Read More ›
Time to Treatment Impacts on Early-Stage Lung Cancer Surgery Outcomes
Lung Cancer
Web Exclusives
Released study results indicate that an interval of ≤50 days from diagnosis to treatment significantly improves outcomes in patients with early-stage lung cancer.
Read More ›
Study Results Show Smoking Cessation Timing Significantly Improves NSCLC Surgery Outcomes
Lung Cancer
Web Exclusives
Smoking cessation ≥3 weeks prior to lung cancer surgery significantly decreases postoperative complications.
Read More ›
Current Selective KRAS G12C Therapies in Non–Small-Cell Lung Cancer and Future Direction for Research
Lung Cancer
Web Exclusives
The chemistry behind selective
KRAS
G12C therapies and potential future research avenues were discussed in a recently released journal article.
Read More ›
Assessing Factors Predictive of Pneumonitis Development with Use of Targeted Therapies in Non–Small-Cell Lung Cancer
Lung Cancer
Web Exclusives
In a recent study, researchers identified several factors associated with the development of pneumonitis with therapies targeting non–small-cell lung cancer.
Read More ›
Best Selection of Line Therapy in Non–Small-Cell Lung Cancer without Genetic Alterations
Lung Cancer
Web Exclusives
Considerations in first-line and second-line therapy selection in non–small-cell lung cancer without genetic alterations were presented in a recent review article.
Read More ›
Immune Checkpoint Inhibitor Use in Non–Small-Cell Lung Cancer Causes Primarily Mild Adverse Events
Lung Cancer
Web Exclusives
Although generally mild adverse events are associated with the use of immune checkpoint inhibitors for non–small-cell lung cancer, occasionally serious complications may result.
Read More ›
Page 2 of 47
1
2
3
4
5
6
7
8
9
10
View the Lastest Issue of TON
Read Issue
Home
Issues
2022
June 2022 - Vol 15 No 3
April 2022 - Vol 15 No 2
February 2022 - Vol 15 No 1
2021
December 2021 - Vol 14 No 6
October 2021 - Vol 14 No 5
August 2021 - Vol 14 No 4
June 2021 - Vol 14 No 3
April 2021 - Vol 14 No 2
February 2021 - Vol 14 No 1
2020
December 2020, Vol 13, No 6
October 2020, Vol 13, No 5
August 2020, Vol 13, No 4
June 2020, Vol 13, No 3
April 2020 - Vol 13, No 2
Issue Archive
Special Issues
Supplements
ASK THE EXPERT:
First-Line Treatment of Metastatic Non-Small-Cell Lung Cancer: Checkmate 9LA
First-Line Treatment of Metastatic Non-Small-Cell Lung Cancer: Checkmate 227
Guide to New FDA Approvals
2021 Year in Review
Multiple Myeloma
Advances in Dual Immunotherapy Cancer Treatments
Ovarian Cancer
HER2-Negative Breast Cancer
Triple-Negative Breast Cancer
Renal-Cell Carcinoma
Biosimilars
Gastrointestinal Cancer
Non–Small-Cell Lung Cancer
Categories
Conference Correspondent
ASCO 2021 - Breast Cancer
ASCO 2020 - Lung Cancer
ASH 2019 Wrap-Up
ASH 2019 MM
Web Exclusives
All Web Exclusives
Breast Cancer Monthly Minutes
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes
Interview with the Innovators
Drug Updates
FDA Approvals, News & Updates
In the News
Online First
Press Releases
Media Library
Videos
Audiocasts
Ask the Experts
Master Class Series
Quick Quiz
CE
Subscribe to The Oncology Nurse-APN/PA
To sign up for our newsletter or print publications, enter your contact information below.
I'd like to receive:
TON
Print Edition
TON
Weekly e‑Newsletter
Afghanistan
Åland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia, Plurinational State of
Bonaire, Sint Eustatius and Saba
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo, the Democratic Republic of the
Cook Islands
Costa Rica
Côte d'Ivoire
Croatia
Cuba
Curaçao
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island and McDonald Islands
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Isle of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia, the former Yugoslav Republic of
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory, Occupied
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint Barthélemy
Saint Helena, Ascension and Tristan da Cunha
Saint Kitts and Nevis
Saint Lucia
Saint Martin (French part)
Saint Pierre and Miquelon
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Sint Maarten (Dutch part)
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan, Province of China
Tajikistan
Tanzania, United Republic of
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela, Bolivarian Republic of
Viet Nam
Virgin Islands, British
Virgin Islands, U.S.
Wallis and Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
I have reviewed and consent to the terms of
TON
's
Privacy Policy
, and
TON
has my permission to retain my information in its database, and to forward pertinent communications to me.